Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders.


Journal

Current drug metabolism
ISSN: 1875-5453
Titre abrégé: Curr Drug Metab
Pays: Netherlands
ID NLM: 100960533

Informations de publication

Date de publication:
2021
Historique:
received: 12 03 2020
revised: 04 08 2020
accepted: 08 09 2020
pubmed: 26 11 2020
medline: 28 12 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

Impressive research steps have been taken for the treatment of neurological disorders in the last few decades. Still, effective treatments of brain related disorders are very less due to problems associated with crossing the blood-brain barrier (BBB), non-specific therapies, and delay in functional recovery of the central nervous system (CNS) after treatment. Striving for novel treatment options for neurological disorders, nanotechnology- derived materials, and devices have gained ground due to inherent features of derivatization/encapsulation with drugs as per the neurological ailments and pharmacological targets. Facile developments/syntheses of the nanomaterials-drug conjugates have also been the driving force for researchers to get into this field. Moreover, the tunable size and hydro/lipophilicity of these nanomaterials are the added advantages that make these materials more acceptable for CNS disorders. These nano-neurotherapeutics (NNTs) systems provide the platform for diagnosis, theranostics, treatments, restoration of CNS disorders, and encourage the translation of NNTs from "bench to bedside". Still, these techniques are in the primary stages of medical development. This review describes the latest advancements and future scenarios of developmental and clinical aspects of polymeric NNTs.

Identifiants

pubmed: 33234099
pii: CDM-EPUB-111766
doi: 10.2174/1389200221666201124123939
doi:

Substances chimiques

Central Nervous System Agents 0
Nanoparticle Drug Delivery System 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-262

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Aashish Sharma (A)

SFI Centre for Research in Medical Devices (CÚRAM), National University of Ireland, Galway, Ireland.

Romila Manchanda (R)

Institute for Quantitative Health Science and Engineering, Michigan State University, 775 Woodlot Dr, East Lansing MI 48824, United States.

Faheem H Pottoo (FH)

Department Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam, 31441, Saudi Arabia.

Ghulam Md Ashraf (GM)

Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH